Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160017/S140

MiniMed 780G System

Medtronic MiniMed, Inc. · Decision date Sep 29, 2026

MEDTECHLEDGER EXPLANATIONP160017/S140

What did the FDA approve?

The FDA record for P160017/S140 shows approval of a revised protocol for the post-approval study of the MiniMed 780G System, a Medtronic Minimed automated insulin dosing device system with single hormonal control under product code OZP. The supplement was filed on the Normal 180 Day Track No User Fee, with the stated supplement reason "Postapproval Study Protocol." The entry describes a protocol change, not a new approval of the whole system; S140 is a supplement to the original P160017 PMA rather than an original decision in its own right.

The database entry does not specify which protocol elements were revised, nor does it report study size, endpoints, timelines or results. The reported purpose is the revised post-approval study protocol, and this record is not independent proof of safety or clinical effectiveness. How the revision relates to the original PMA's scope cannot be determined from the supplied fields beyond the supplement identifier.

FDA approval order statement

Approval of the revised protocol for the post-approval study (PAS)
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Clinical Chemistry
Decision date
Sep 29, 2026
FDA change category
Postapproval Study Protocol

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160017/S140
Regulatory pathway
PMA supplement
Product code
OZP
Decision code
APPR
Decision date
Sep 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated insulin dosing device system, single hormonal control.

Product code
OZP
FDA device class
3

For the original device and its historical approval scope, see PMA P160017. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160017 · Original PMA

    MiniMed 670G System

  2. P160017/S140 received

    Application receipt date recorded by FDA.

  3. P160017/S140 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P160017. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160017

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic MiniMed, Inc.PMA approvalSep 28, 2016FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic MiniMed, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
18000 Devonshire St., Northridge, CA, 91325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records